Cardiac Science's Powerheart G3 AED receives Japanese regulatory approval

Cardiac Science Corporation, a global leader in automated external defibrillators (AEDs) and diagnostic cardiac monitoring devices, announced today that the Japan Ministry of Health, Labor, and Welfare approved a new model of its Powerheart® G3 AED. The company is partnering with Omron Healthcare to distribute its AEDs in Japan. Japan-based Omron is a leading healthcare company dedicated to prevention of heart disease.

"We are proud to partner with Omron to distribute our Powerheart AED in Japan," said Dave Marver, Chief Executive Officer, Cardiac Science Corporation. "They are a highly reputable company with an impressive sales and service capability. We were once AED market leaders in Japan and we look forward to reclaiming that status with Omron as our trusted partner."

Japan is the second largest AED market in the world with 65,000 AEDs sold annually. Cardiac Science and Omron Healthcare are currently engaged in market launch preparations, with commercial release and first revenue sales expected in August, 2011.